FRANCA, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 4.826
EU - Europa 3.014
AS - Asia 2.495
SA - Sud America 331
AF - Africa 91
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.777
Nazione #
US - Stati Uniti d'America 4.729
SG - Singapore 872
PL - Polonia 668
IT - Italia 664
CN - Cina 536
SE - Svezia 268
DE - Germania 266
VN - Vietnam 256
BR - Brasile 249
HK - Hong Kong 239
UA - Ucraina 190
FI - Finlandia 188
FR - Francia 168
GB - Regno Unito 145
BD - Bangladesh 130
RU - Federazione Russa 101
KR - Corea 95
IN - India 79
TR - Turchia 77
NL - Olanda 72
IE - Irlanda 64
JP - Giappone 53
BG - Bulgaria 47
CA - Canada 36
MX - Messico 36
ES - Italia 33
AR - Argentina 30
BE - Belgio 24
MA - Marocco 21
PK - Pakistan 19
CH - Svizzera 18
IQ - Iraq 17
AT - Austria 16
AU - Australia 16
PT - Portogallo 16
EG - Egitto 14
ID - Indonesia 14
SN - Senegal 14
TH - Thailandia 14
SA - Arabia Saudita 13
TN - Tunisia 13
CL - Cile 11
SI - Slovenia 11
JO - Giordania 10
UZ - Uzbekistan 10
EC - Ecuador 9
PE - Perù 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
AE - Emirati Arabi Uniti 7
DK - Danimarca 7
IR - Iran 7
PY - Paraguay 7
CO - Colombia 6
GR - Grecia 6
KE - Kenya 6
MY - Malesia 6
PH - Filippine 6
TW - Taiwan 6
VE - Venezuela 6
CR - Costa Rica 5
NO - Norvegia 5
RO - Romania 5
AZ - Azerbaigian 4
JM - Giamaica 4
PR - Porto Rico 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
IL - Israele 3
LT - Lituania 3
MD - Moldavia 3
PS - Palestinian Territory 3
UY - Uruguay 3
AL - Albania 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GH - Ghana 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 10.762
Città #
Warsaw 609
Ashburn 548
Singapore 515
Woodbridge 397
Fairfield 378
Ann Arbor 370
Chandler 331
San Jose 298
Hong Kong 233
Trieste 233
Houston 230
Wilmington 196
Jacksonville 172
Seattle 171
Cambridge 139
Munich 134
Beijing 121
Helsinki 110
Ho Chi Minh City 87
Princeton 87
Seoul 85
Boardman 82
Hefei 78
Los Angeles 71
Hanoi 64
Chicago 60
Council Bluffs 55
Milan 53
Dublin 51
Lauterbourg 49
Santa Clara 48
Izmir 47
Sofia 47
London 46
Moscow 45
Zgierz 45
Columbus 43
New York 43
Dallas 41
Frankfurt am Main 39
The Dalles 38
São Paulo 36
Buffalo 32
Dearborn 31
Düsseldorf 28
Tokyo 27
Rome 25
Bremen 23
Brussels 21
Casablanca 17
Falls Church 16
Fano 16
Phoenix 16
Shanghai 16
Turku 16
Atlanta 14
Dakar 14
Orem 14
San Diego 14
Guangzhou 13
Mumbai 13
Shannon 13
Chennai 12
Curitiba 12
Des Moines 12
Redondo Beach 12
Bern 11
Genoa 11
Istanbul 11
Washington 11
Manchester 10
Montreal 10
Nuremberg 10
Redwood City 10
Stockholm 10
Tashkent 10
Amsterdam 9
Baghdad 9
Brooklyn 9
Denver 9
Nanjing 9
Sydney 9
Venice 9
Bengaluru 8
Chihuahua City 8
Dong Ket 8
Fremont 8
Hangzhou 8
Ljubljana 8
Madrid 8
Memphis 8
Toronto 8
Vienna 8
Amman 7
Bangkok 7
Brasília 7
Cairo 7
Campo Grande 7
Haiphong 7
Jinan 7
Totale 7.248
Nome #
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 510
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 469
Pharmacogenetics of thiopurines 451
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 428
Pharmacogenetics of treatments for inflammatory bowel disease 380
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 327
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 292
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 285
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 278
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 266
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 265
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 260
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 259
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 256
Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. 242
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies 233
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol 230
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 230
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 227
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 223
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 220
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. 216
Human Immunodeficiency Virus (HIV-1) Auxiliary Protein Vif and Cellular APOBEC Deaminases: Their Roles Unveiled? 209
Glutathione S-Transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. 204
TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype 203
Personalized therapies in pediatric inflammatory and autoimmune diseases. 201
Heterodimeric amino acid transporter glycoprotein domains determining functional subunit association 195
Expression of kidney and liver bilitranslocase in response to acute biliary obstruction. 195
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. 192
The ectopic F(O)F(1) ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein IF1. 189
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 189
Human DEAD-box ATPase DDX3 shows a relaxed nucleoside substrate specificity 180
DMET™ Plus array delivers results in good concordance with those of several lower-throughput genotyping methods in patient samples. 177
Identification and Functional Characterization of Bilitranslocase in Sea-Bass (Dicentrarchus labrax) Hepatopancreas 168
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 167
Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia 165
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 164
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 158
Processes for incorporation of pharmacogenetic tests and interpretations in medical records for clinical practice. 156
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 156
APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism 151
ITPA genetic polymorphism is possibly associated with survival rate in Korean children with acute lymphoblastic leukemia. 150
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells 145
Biomarkers for gastrointestinal adverse events related to thiopurine therapy 140
Impact of mercaptopurine metabolites on disease outcome in the AIEOP-BFM ALL 2009 protocol for acute lymphoblastic leukemia 130
SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation 129
Pharmacological evaluation of drug therapies in Aicardi-Goutières syndrome: insights from patient-derived neural stem cells 116
Pharmacogenetics of glucocorticoid response 115
The Role of Candidate Polymorphisms in Drug Transporter Genes on High-Dose Methotrexate in the Consolidation Phase of the AIEOP-BFM ALL 2009 Protocol 109
Totale 11.000
Categoria #
all - tutte 29.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.709


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202161 0 0 0 0 0 0 0 0 0 0 0 61
2021/2022577 32 38 28 31 24 51 46 28 68 61 40 130
2022/20231.008 96 155 62 145 96 160 8 94 108 30 46 8
2023/2024685 34 54 30 46 65 48 114 116 7 28 79 64
2024/20251.767 51 91 114 168 159 174 157 137 231 223 139 123
2025/20263.315 352 132 214 244 299 265 487 102 430 472 236 82
Totale 11.000